Paradoxical pustular psoriasis in a patient with spondyloarthritis treated with secukinumab
Abstract Secukinumab is a monoclonal antibody used to specifically inhibit pathologic interleukin‐17 and therefore effectively manage conditions like plaque psoriasis, psoriatic arthritis and ankylosing spondylitis. Although we know that antitumor necrosis factor molecules can cause paradoxical pust...
Saved in:
Main Authors: | Daniela Anghel (Author), Mihaela Georgescu (Author), Marcela Poenaru (Author), Diana Maria Orleanu (Author), George Sorin Tiplica (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Secukinumab-induced paradoxical palmoplantar pustular psoriasis
by: Yıldız Gürsel Ürün, et al.
Published: (2022) -
Paradoxical flare of psoriasis, psoriatic spondyloarthritis, and psoriatic uveitis after switching from infliximab to secukinumab
by: Peiqi Su, et al.
Published: (2017) -
Secukinumab in generalized pustular psoriasis
by: Shraddha Madanagobalane
Published: (2018) -
Clinical analysis of secukinumab in the treatment of childhood generalized pustular psoriasis
by: Min YU, et al.
Published: (2024) -
The utility of IL36RN mutation analysis in an elderly patient with generalized pustular psoriasis patient treated with secukinumab
by: Satoko Minakawa, et al.
Published: (2023)